Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy

被引：8

作者：

Yokoseki, Akiko ^{[1
]}

Saji, Etsuji ^{[1
]}

Arakawa, Musashi ^{[1
]}

Hokari, Mariko ^{[1
]}

Ishiguro, Takanobu ^{[1
]}

Yanagimura, Fumihiro ^{[1
]}

Ishihara, Tomohiko ^{[1
]}

Okamoto, Kouichirou ^{[2
]}

Nishizawa, Masatoyo ^{[1
]}

Kawachi, Izumi ^{[1
]}

机构：

[1] Niigata Univ, Dept Neurol, Brain Res Inst, Niigata 9518585, Japan

[2] Niigata Univ, Dept Neurosurg, Brain Res Inst, Niigata 9518585, Japan

来源：

MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 09期

关键词：

Fingolimod; multiple sclerosis; CCR7; CSF; compartmentalized immune response; FTY720;

D O I：

10.1177/1352458513481395

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Fingolimod acts as a functional antagonist of the sphingosine-1-phosphate receptor, and it traps lymphocytes in secondary lymphoid organs and precludes their migration into the central nervous system. We report the case of a patient who suffered a relatively severe relapse of multiple sclerosis (MS) during the initial 3 months of fingolimod therapy, with retention of CCR7 expression on CD4(+) T cells in the cerebrospinal fluid (CSF) despite decreased numbers of lymphocytes and decreased expression of CCR7 on CD4(+) T cells in the blood. These data suggest that fingolimod may cause differential effects on the CSF and blood lymphocytes of patients with MS during the initial months of therapy.

引用

页码：1230 / 1233

页数：4

共 27 条

[1] Severe multiple sclerosis relapse under fingolimod therapy
Meluzinova, E.
Bojar, M.
Havrdova, E.
Liskova, P.
Kappos, L.
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 459 - 459
[2] Severe Multiple Sclerosis Relapse under Fingolimod Therapy: Incident or Coincidence?
Berthele, Achim
Castrop, Florian
Hemmer, Bernhard
NEUROLOGY, 2011, 76 (09) : A248 - A248
[3] SEVERE MULTIPLE SCLEROSIS RELAPSE UNDER FINGOLIMOD THERAPY: INCIDENT OR COINCIDENCE?
Castrop, F.
Kowarik, M. C.
Albrecht, H.
Krause, M.
Haslinger, B.
Zimmer, C.
Berthele, A.
Hemmer, B.
NEUROLOGY, 2012, 78 (12) : 928 - 930
[4] CD56 positivity of T cells as a candidate of a predictive biomarker for relapse of multiple sclerosis under fingolimod therapy
Fujii, C.
Kondo, T.
Ochi, H.
Okada, Y.
Hashi, Y.
Matsumoto, S.
Takahashi, R.
Nakagawa, M.
Mizuno, T.
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 365 - 365
[5] Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients
Muls, Nathalie
Dang, Hong Anh
Sindic, Christian J. M.
van Pesch, Vincent
PLOS ONE, 2014, 9 (11):
[6] Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy
Chihiro Fujii
Takayuki Kondo
Hirofumi Ochi
Yoichiro Okada
Yuichiro Hashi
Tetsuya Adachi
Masaharu Shin-Ya
Sadayuki Matsumoto
Ryosuke Takahashi
Masanori Nakagawa
Toshiki Mizuno
Scientific Reports, 6
[7] Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy
Fujii, Chihiro
Kondo, Takayuki
Ochi, Hirofumi
Okada, Yoichiro
Hashi, Yuichiro
Adachi, Tetsuya
Shin-Ya, Masaharu
Matsumoto, Sadayuki
Takahashi, Ryosuke
Nakagawa, Masanori
Mizuno, Toshiki
SCIENTIFIC REPORTS, 2016, 6
[8] Characterization of CCR4+T cells in multiple sclerosis and modulation by therapy
Karni, A
Balashov, KE
Hancock, WW
Khoury, SJ
Weiner, HL
NEUROLOGY, 2000, 54 (07) : A148 - A149
[9] Interferon signaling alterations in CCR7-expressing B16 murine melanoma cells that show diminished recruitment of intratumoral CD8+T cells
Fang, L.
Hwang, S. T.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S135 - S135
[10] Enrichment of CD161+CCR6+gamma delta T cells in the CSF of multiple sclerosis patients
Schirmer, L.
Rothhammer, V.
Petermann, F.
Carassiti, D.
Grummel, V.
Reynolds, R.
Hemmer, B.
Korn, T.
MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S29 - S30

← 1 2 3 →